| Literature DB >> 24715051 |
Peng Tian1, Jie Li2, Xiang Liu1, Yuxi Li2, Meiheng Chen1, Yun Ma1, Yi Qing Zheng1, Yonggui Fu2, Hua Zou1.
Abstract
Nasal polyps (NP) is highly associated with the disorder of immune cells. Alternative polyadenylation (APA) produces mRNA isoforms with different length of 3'‑untranslated region (UTR) and regulates gene expression. It has been proven that this APA-mediated regulation of 3'UTR length is an immune-associated phenomenon. The aim of this study was to investigate the genome-wide alternative tandem 3'UTR length switching events in non-eosinophilic nasal polyp tissue. Thirteen patients diagnosed as having non-eosinophilic nasal polyps were included in this study. Nasal polyp tissue and control mucosa were collected during surgery. The 3' end library of cDNA was constructed. The recovered libraries were sequenced with second sequencing technology, and the sequencing data were analyzed by an in-house bioinformatics pipeline. Tandem 3'UTR length switching between samples was detected by a test of linear trend alternative to independence. We found a significant alteration in the tandem 3'UTR length in 1,920 genes in nasal polyp samples. Functional annotation results showed that several gene ontology (GO) terms were enriched in the list of genes with switched APA sites, including regulation of transcription, macromolecule catabolic localization and mRNA processing.The results suggested that APA-mediated alternative 3'UTR regulation plays an important role in the post-transcriptional regulation of gene expression in non-eosinophilic nasal polyps.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24715051 PMCID: PMC4055440 DOI: 10.3892/ijmm.2014.1734
Source DB: PubMed Journal: Int J Mol Med ISSN: 1107-3756 Impact factor: 4.101
Data of inflammatory cell frequency in nasal polyp tissue of non-eosinophilic CRSwNP patients.
| Case | Age (yrs.)/Gender | Lymphocytes (%) | Eosinophil (%) |
|---|---|---|---|
| 1 | 23/Male | 48.6 | 4.9 |
| 2 | 30/Male | 54.4 | 4.6 |
| 3 | 35/Female | 58.3 | 4.5 |
| 4 | 47/Male | 93.6 | 4.3 |
| 5 | 68/Female | 59.2 | 0 |
| 6 | 31/Female | 56.2 | 4.8 |
| 7 | 45/Male | 68.3 | 4.6 |
| 8 | 35/Male | 45.3 | 2 |
| 9 | 36/Female | 34.4 | 3.5 |
| 10 | 41/Female | 60.3 | 4.5 |
| 11 | 45/Male | 58.3 | 3.7 |
| 12 | 20/Female | 37.2 | 4.1 |
| 13 | 43/Female | 93.6 | 3.5 |
All the NPs were non-eosinophilic.
Figure 1Histological analysis showing the types of nasal polyps in Chinese patients. (A) Nasal endoscopic findings of nasal polyps. (B) Representative paranasal sinus computed tomography (CT) findings of nasal polyps. (C) Histological appearance (magnification, ×100). (D) Histological appearance (magnification, ×400).
Summary statistics for solexa sequencing and mapping to genome (hg19).
| Items | Case 55C | Case 55P | Case 36C | Case 36P | Combined |
|---|---|---|---|---|---|
| Raw reads | 30,415,461 | 29,508,427 | 20,287,449 | 22,109,878 | 102,321,215 |
| Qualified reads | 27,625,126 | 27,287,883 | 16,827,740 | 17,809,279 | 89,550,028 (87.5%) |
| Mapped to genome | 25,514,090 | 25,966,853 | 14,800,273 | 15,205,149 | 81,486,365 (79.3%) |
| Uniquely mapped to genome | 19,239,132 | 19,756,273 | 10,240,035 | 10,469,750 | 59,705,190 (58.4%) |
| Mapped to nuclear genome | 18,739,483 | 19,285,503 | 10,022,826 | 10,268,225 | 58,316,037 (57.0%) |
| After IP filter | 17,911,620 | 18,568,301 | 9,309,362 | 9,526,473 | 45,789,283 (44.8%) |
| Genes sampled by reads | 17,312 | 17,143 | 16,469 | 16,652 | 17,921 |
| Cleavage clusters | 84,155 | 81,992 | 58,762 | 60,183 | 99,866 |
| Known polyA sites sampled | 26,783 | 26,508 | 22,441 | 22,354 | 27,643 |
| Putative novel polyA sites | 57,372 | 55,484 | 36,321 | 37,829 | 72,223 |
| Genes sampled by cleavage clusters | 16,598 | 16,497 | 15,596 | 15,634 | 17,042 |
IP, internal priming; C, control mucosa; P, polyp tissue.
Figure 2The characteristics of the sequencing data. (A) The genomic locations of the poly(A) sites in all genes. (B) A histogram of the number of reads for the UCSC canonical gene. (C) The genomic locations of reads that were uniquely mapped to the nuclear genome after internal priming filtering. (D) A bar graph showing the number of genes with a different number of poly(A) sites, each number ‘n’ on the x-axis means n or more APA isoforms were detected. (E) Examples of tandem-UTR genes with two, three, and seven 3′UTR isoforms.
Figure 3The representative example shows an association between APA site switching and gene expression levels of nasal polyp tissue and normal mucosa. A larger positive r-value shows that nasal polyp samples are prone to use longer tandem 3′UTRs. Genes with significant switching to longer (blue) or shorter (red) tandem 3′UTRs in nasal polyp samples (FDR=0.01; Materials and methods) are colored. The y-axis shows the logarithm of the expression levels of genes from the nasal polyp sample corresponding to the nasal mucosal sample.
Validation of 3′UTR switching in nasal polyp compared with control mucosa using qRT-PCR
| Illumina sequencing data | qRT-PCR | ||||||
|---|---|---|---|---|---|---|---|
|
|
| ||||||
| UCSC ID | 3′UTR | Pearson’s r | FDR | 3′UTR | P-ER | C-ER | P-value |
| uc011jzo.1 | Shortened | −0.12009 | 4.82E-03 | Shortened | 31.71780 | 15.16862 | <0.001 |
| uc003vej.2 | Lengthened | 0.39509 | 2.85E-08 | Lengthened | 8.820350 | 13.59187 | <0.001 |
| uc001qsz.3 | Lengthened | 0.226097 | 4.00E-05 | Lengthened | 9.961412 | 12.59653 | <0.001 |
| uc002jnx.3 | Shortened | −0.182239 | 1.42E-08 | Shortened | 2.375458 | 1.896878 | <0.001 |
ER, expression ratios of the common region to the extended region; P, polyp tissue; C, control tissue. Pearson’s r, a larger positive/negative value indicates that longer/shorter tandem UTRs are prone to be used in the nasal polyp.
Enrichment results of genes with significantly shorter 3′UTR isoforms involved in various GO functional categories.
| Categories | Count | P-value | Benjamini |
|---|---|---|---|
| GOTERM_BP_FAT | |||
| Transcription | 151 | 1.70E-07 | 4.20E-04 |
| Regulation of transcription | 167 | 3.50E-05 | 1.30E-02 |
| Intracellular protein transport | 40 | 4.50E-06 | 5.70E-03 |
| Intracellular transport | 58 | 1.10E-05 | 8.90E-03 |
| Protein targeting | 27 | 1.40E-05 | 8.90E-03 |
| Protein transport | 64 | 1.60E-05 | 8.30E-03 |
| Establishment of protein localization | 64 | 2.20E-05 | 9.40E-03 |
| Cellular protein localization | 40 | 4.00E-05 | 1.30E-02 |
| Cellular macromolecule localization | 40 | 4.70E-05 | 1.30E-02 |
| Protein localization | 69 | 6.90E-05 | 1.50E-02 |
| Modification-dependent macromolecule catabolic process | 50 | 6.60E-05 | 1.70E-02 |
| Modification-dependent protein catabolic process | 50 | 6.60E-05 | 1.70E-02 |
| Protein catabolic process | 53 | 6.90E-05 | 1.60E-02 |
| Proteolysis involved in cellular protein catabolic process | 51 | 1.00E-04 | 2.00E-02 |
| Cellular protein catabolic process | 51 | 1.20E-04 | 2.10E-02 |
| RNA splicing | 29 | 2.60E-04 | 4.30E-02 |
| GOTERM_CC_FAT | |||
| Membrane-enclosed lumen | 123 | 1.50E-05 | 6.60E-03 |
| Organelle lumen | 121 | 1.50E-05 | 3.40E-03 |
| Nuclear lumen | 101 | 1.50E-05 | 2.30E-03 |
| Nucleoplasm part | 49 | 1.60E-05 | 1.80E-03 |
| Intracellular organelle lumen | 118 | 2.30E-05 | 2.10E-03 |
| Nucleoplasm | 66 | 8.80E-05 | 6.50E-03 |
| Spliceosome | 17 | 3.50E-04 | 2.20E-02 |
Enrichment results of genes with significantly longer 3′UTR isoforms involved in various GO functional categories.
| Categories | Count | P-value | Benjamini |
|---|---|---|---|
| GOTERM_BP_FAT | |||
| Protein localization | 82 | 3.70E-06 | 1.00E-02 |
| Cellular macromolecule localization | 47 | 5.00E-06 | 6.80E-03 |
| Cellular protein localization | 46 | 9.20E-06 | 8.40E-03 |
| mRNA metabolic process | 42 | 1.80E-05 | 1.20E-02 |
| mRNA processing | 55 | 2.50E-05 | 1.40E-02 |
| Establishment of protein localization | 70 | 4.30E-05 | 2.00E-02 |
| Protein transport | 69 | 5.90E-05 | 1.80E-02 |
| GOTERM_CC_FAT | |||
| Organelle lumen | 138 | 1.80E-05 | 8.70E-03 |
| Intracellular organelle lumen | 135 | 2.30E-05 | 5.50E-03 |
| Membrane-enclosed lumen | 138 | 4.80E-05 | 7.50E-03 |
| Nuclear lumen | 111 | 1.10E-04 | 1.30E-02 |
| Golgi apparatus | 71 | 4.60E-04 | 4.30E-02 |
Figure 4qRT-PCR analyses in 10 additional patients suffering from NE-CRSwNP. (A) CD163. (B) GRB2. (C) BCAP29. (D) TAX1BP. cUTR/eUTR, common UTR/extensive UTR, the expression ratios of the shortened region to the lengthened region. *P<0.05.